Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Tables)

v3.26.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of warrants activity
                       
   

Pre-Funded

Warrants

 

Series A

Common

Warrants

 

Series B

Common

Warrants

Outstanding at December 31, 2025     –       –       –  
Issued     279,330       279,330       279,330  
Exercised     (279,330 )     (279,330 )     –  
Expired or cancelled     –       –       –  
Outstanding at September 30, 2026     –       –       279,330  
Schedule of assumptions
   
    September 30, 2026
Risk-free interest rate   3.79% and 3.83%  
Expected life of the options   5.5 years  
Expected volatility   135.83% and 134.99%  
Expected dividend yield   0%  
Schedule of option activity
                       
    Number of Options     Weighted average exercise price     Weighted Average Remaining Contractual Life    

Aggregate

Intrinsic Value

 
Outstanding at December 31, 2025     1,904     $ 1,208.00       6.32                –  
Granted     338     $ 30.89       –       –  
Exercised     –       –       –       –  
Cancelled or forfeited     –       –       –       –  
Outstanding at September 30, 2026     2,242     $ 1,030.72       6.09       –  
Exercisable as of September 30, 2026     2,143     $ 1,076.54       5.99       –